Quality of anticoagulation and use of warfarin-interacting medications in long-term care: A chart review [PDF]
, 2008 Madeleine Verhovsek +7 more
openalex +1 more source
RETROPERITONEAL HEMORRHAGE AS A RARE COMPLICATION OF ANTIBIOTIC THERAPY FOR ODONTOGENIC INFECTION AND WARFARIN THERAPY IN A PATENT WITH CONGENITAL HEART DISEASE [PDF]
, 2023 Ali Ghorbani
openalex +1 more source
Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley +1 more source
Research in Molecular Medicine, 2016 Background: Warfarin is a common anticoagulant drug that has a narrow therapeutic index; higher dose causes excessive bleeding and lower dose leads to cerebrovascular clotting and stroke in patients.
Reyhaneh Kameli +7 more
doaj
Molecular Testing in Sickle Cell Disease: From Newborn Screening to Transfusion Care
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Sickle cell disease (SCD) is one of the most frequent monogenic diseases worldwide and a highly heterogeneous and complex disease. SCD care carries several challenges. This includes early and accurate diagnosis as well as optimal red blood cell transfusion matching in this population carrying a high risk of alloimmunization.
Thomas Pincez, Yves D. Pastore
wiley +1 more source
Extensive Pulmonary Embolism in late pregnancy associated with Anticardiolipin Antibodies [PDF]
, 2004 The leading cause of morbidity and mortality during pregnancy and the puerperium is venous thromboembolism. Though uncommon, the risk is five times higher in a pregnant woman than in a non-pregnant woman of similar age.1,2 In pregnancy, all three ...
Brincat, Mark P. +5 more
core
Healthcare resource utilization and costs among nonvalvular atrial fibrillation patients initiating rivaroxaban or warfarin in skilled nursing facilities: a retrospective cohort study [PDF]
, 2019 Vishakha Mittal +5 more
openalex +1 more source
International Journal of Laboratory Hematology, EarlyView.ABSTRACT Introduction The International Society of Thrombosis and Hemostasis (ISTH) guidelines suggest a three‐step evaluation for the detection of lupus anticoagulant (LA), including screening, mixing, and confirmation. According to the guidelines, the LA assay based on activated partial thromboplastin time (APTT) should include an initial screening ...
Bárbara G. Barion +7 more
wiley +1 more source
Alternative therapy interaction with warfarin: what doctors should know
Кардиоваскулярная терапия и профилактика, 2010 Warfarin effectiveness and safety is substantially affected by concurrent therapy. This paper reviews the main mechanisms of warfarin interactions with other agents, which underlie adverse effect development: platelet dysfunction, gastro-intestinal ...
T. B. Kozlova +3 more
doaj
The quality of warfarin therapy and CHA2DS2-VASc score associate with the incidence of myocardial infarction and cardiovascular outcome in patients with atrial fibrillation: data from the nationwide FinWAF Registry [PDF]
, 2018 M.J. Pekka Raatikainen +5 more
openalex +1 more source